Global Protein/Antibody Engineering Market to Reach USD 18.4 Billion by 2036 Driven by Generative AI, Rational Design, and Developability-First Biologics
The global protein and antibody engineering market is undergoing a structural paradigm shift, transitioning from traditional physical screening paradigms to a "developability-first" engineering model, according to latest insights by Future Market Insights. Driven by the need to lower late-stage clinical attrition rates, biopharmaceutical companies are integrating generative AI models and high-throughput biophysical assays to optimize candidate molecules for affinity, stability, reduced immunogenicity, and extended half-life long before clinical trial entry.
